Actinic keratosis metrics.
Burstein SE, Maibach H.
Arch Dermatol Res. 2024 Aug 20;316(8):543. doi: 10.1007/s00403-024-03305-5.
Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology.
Dirschka T, Gupta G, Micali G, Stockfleth E, Basset-Séguin N, Del Marmol V, Dummer R, Jemec GBE, Malvehy J, Peris K, Puig S, Stratigos AJ, Zalaudek I, Pellacani G.
J Dermatolog Treat. 2017 Aug;28(5):431-442. doi: 10.1080/09546634.2016.1254328. Epub 2016 Nov 13.
Actinic keratosis and imiquimod: a review of novel carriers and patents.
Sharma M, Sharma G, Singh B, Katare OP.
Expert Opin Drug Deliv. 2019 Feb;16(2):101-112. doi: 10.1080/17425247.2019.1560418. Epub 2018 Dec 24.
Actinic keratosis: where do we stand and where is the future going to take us?
Cramer P, Stockfleth E.
Expert Opin Emerg Drugs. 2020 Mar;25(1):49-58. doi: 10.1080/14728214.2020.1730810. Epub 2020 Feb 20.
Actinic Keratosis: Current Therapies and Insights Into New Treatments.
Hashim PW, Chen T, Rigel D, Bhatia N, Kircik LH.
J Drugs Dermatol. 2019 May 1;18(5):s161-166..
[Actinic Keratosis].
Dejaco D, Hauser U, Zelger B, Riechelmann H.
Laryngorhinootologie. 2015 Jul;94(7):467-79; quiz 480-1. doi: 10.1055/s-0035-1554655. Epub 2015 Jun 30.
Diagnosis and therapy of actinic keratosis.
Thamm JR, Welzel J, Schuh S.
J Dtsch Dermatol Ges. 2024 May;22(5):675-690. doi: 10.1111/ddg.15288. Epub 2024 Mar 8.
Classifying Actinic Keratosis: What the Reality of Everyday Clinical Practice Shows Us.
Schmitz L, Broganelli P, Boada A.
J Drugs Dermatol. 2022 Aug 1;21(8):845-849. doi: 10.36849/JDD.6704.
Tirbanibulin for the Treatment of Actinic Keratosis: A Review.
Miller AC, Adjei S, Temiz LA, Tyring SK.
Skin Therapy Lett. 2022 Jul;27(4):4-7.
Actinic Keratosis Pathogenesis Update and New Patents.
Cantisani C, Paolino G, Melis M, Faina V, Romaniello F, Didona D, Cardone M, Calvieri S.
Recent Pat Inflamm Allergy Drug Discov. 2016;10(1):40-48. doi: 10.2174/1872213x10666160504104825.
